IRON

Disc Medicine (IRON)

About Disc Medicine (IRON)

Disc Medicine, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of treatments for hematologic diseases. It assembles a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. The company was founded in October 2017 and is headquartered in Watertown, MA.

Details

Daily high
$91.78
Daily low
$90.16
Price at open
$90.90
52 Week High
$99.50
52 Week Low
$30.82
Market cap
3.5B
Dividend yield
0.00%
Volume
639,420
Avg. volume
564,925
P/E ratio
-17.17

Disc Medicine News

Details

Daily high
$91.78
Daily low
$90.16
Price at open
$90.90
52 Week High
$99.50
52 Week Low
$30.82
Market cap
3.5B
Dividend yield
0.00%
Volume
639,420
Avg. volume
564,925
P/E ratio
-17.17